New activity is brewing for Telomir Pharmaceuticals, Inc. ( (TELO) ). The company has submitted a Form DEFM14A to the SEC, indicating an upcoming shareholder vote. This form gives shareholders all the information they need to develop an informed vote. Read on to learn more about the proposed company action.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Telomir Pharmaceuticals has called a virtual annual meeting of shareholders for March 23, 2026, to vote on a slate of proposals, including director elections, auditor ratification, amendments to its omnibus incentive plan and bylaws, and approval of option grants to non-executive directors. The agenda also includes authorization to adjourn the meeting if needed to secure sufficient support for key items.
The centerpiece proposal seeks shareholder approval for issuing more than 20% of Telomir’s outstanding stock to complete a merger with privately held TELI Pharmaceuticals, which will become a wholly owned subsidiary and leave legacy Telomir and TELI holders each owning about half of the post-merger company. Telomir’s board has unanimously endorsed the merger and related proposals as fair and in the best interests of shareholders, signaling a transformative step intended to reshape the company’s scale and profile while maintaining its Nasdaq listing under the TELO ticker.
The most recent analyst rating on (TELO) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Telomir Pharmaceuticals, Inc. stock, see the TELO Stock Forecast page.
More about Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc. is a Miami-based biotechnology company whose common stock trades on the Nasdaq Global Market under the symbol TELO. The company operates in the pharmaceutical sector and is focused on drug development, seeking to expand its platform and capabilities through strategic transactions and corporate governance changes.
Average Trading Volume: 300,908
Technical Sentiment Signal: Sell
Current Market Cap: $39.54M
Find detailed analytics on TELO stock on TipRanks’ Stock Analysis page.